SELEGILINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Selegiline, and what generic alternatives are available?
Selegiline is a drug marketed by Apotex, Lannett Co Inc, Novitium Pharma, Rising, Chartwell Molecules, Cosette, G And W Labs Inc, I3 Pharms, Kenton, and Quagen. and is included in fourteen NDAs.
The generic ingredient in SELEGILINE is selegiline hydrochloride. There are seventeen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the selegiline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Selegiline
A generic version of SELEGILINE was approved as selegiline hydrochloride by I3 PHARMS on April 1st, 1997.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SELEGILINE?
- What are the global sales for SELEGILINE?
- What is Average Wholesale Price for SELEGILINE?
Summary for SELEGILINE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 14 |
| Drug Prices: | Drug price information for SELEGILINE |
| DailyMed Link: | SELEGILINE at DailyMed |
Recent Clinical Trials for SELEGILINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Ibadan | Phase 1/Phase 2 |
| E-Group ICT Software Informatikai Zrt. | Phase 2 |
| László Mangel | Phase 2 |
Medical Subject Heading (MeSH) Categories for SELEGILINE
Anatomical Therapeutic Chemical (ATC) Classes for SELEGILINE
US Patents and Regulatory Information for SELEGILINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | CAPSULE;ORAL | 075321-001 | Dec 4, 1998 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Chartwell Molecules | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | TABLET;ORAL | 074641-001 | Aug 2, 1996 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rising | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | CAPSULE;ORAL | 206803-001 | Apr 2, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Kenton | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | TABLET;ORAL | 074912-001 | Apr 30, 1998 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
